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Human rhinoviruses (HRVs) are common respiratory pathogens associated with mild upper
respiratory tract infections, but also increasingly recognized in the aetiology of severe lower
respiratory tract disease. Wider use of molecular diagnostics has led to a recent reappraisal of
HRV genetic diversity, including the discovery of HRV species C (HRV-C), which is refractory to
traditional virus isolation procedures. Although it is heterogeneous genetically, there has to date
been no attempt to classify HRV-C into types analogous to the multiple serotypes identified for
HRV-A and -B and among human enteroviruses. Direct investigation of cross-neutralization
properties of HRV-C is precluded by the lack of methods for in vitro culture, but sequences from
the capsid genes (VP1 and partial VP4/VP2) show evidence for marked phylogenetic clustering,
suggesting the possibility of a genetically based system comparable to that used for the
assignment of new enterovirus types. We propose a threshold of 13% divergence for VP1
nucleotide sequences for type assignment, a level that classifies the current dataset of 86 HRV-C
VP1 sequences into a total of 33 types. We recognize, however, that most HRV-C sequence data
have been collected in the VP4/VP2 region (currently 701 sequences between positions 615 and
1043). We propose a subsidiary classification of variants showing .10% divergence in VP4/
VP2, but lacking VP1 sequences, to 28 provisionally assigned types (subject to confirmation once
VP1 sequences are determined). These proposals will assist in future epidemiological and clinical
studies of HRV-C conducted by different groups worldwide, and provide the foundation for future
exploration of type-associated differences in clinical presentations and biological properties.
Introduction
Human rhinoviruses (HRVs) are highly prevalent respi-
ratory pathogens, most commonly associated with mild
upper respiratory tract disease and exacerbations of pre-
existing respiratory disease such as asthma. They are also
increasingly recognized as underlying more severe disease
manifestations, such as bronchiolitis in young children and
in the immunosuppressed. The increasing use of molecular
methods for respiratory virus screening has contributed to
this reappraisal of rhinoviruses, as has the recent discovery
of an entirely novel rhinovirus group, refractory to
previously used virus isolation methods but now known
to be highly prevalent and widely circulating worldwide
(Arden et al., 2006; Kaiser et al., 2006; Lamson et al., 2006;
Kistler et al., 2007; Lau et al., 2007; Lee et al., 2007;
McErlean et al., 2007; Renwick et al., 2007; Olenec et al.,
2010).
These newly characterized rhinoviruses have been pro-
posed to belong to a novel species of rhinovirus
(designated species C; HRV-C), recognizing their substan-
tial sequence divergence from other classified species
within the genus Enterovirus of picornaviruses (Carstens,
2010; Knowles, 2010) (Fig. 1a). Clinically and biologically,
they share many attributes with the other designated HRV
species, HRV-A and -B. Most studies of HRV-C disease
associations, typically focused on children from asthmatic
and/or hospital-based populations (Arden & Mackay,
2010), have demonstrated a similarly broad range of
clinical outcomes to those observed in HRV-A and -B
infections and, indeed, with other respiratory viruses. Some
A full list of all HRV-C variants characterized to date, categorized into a
total of 61 confirmed or provisionally assigned types, is available with the
online version of this paper.
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studies show no difference in clinical outcome between
HRV species (Lau et al., 2007; Piotrowska et al., 2009),
whereas others provide evidence for a more frequent role of
HRV-C in lower respiratory tract disease, febrile wheeze in
infants and toddlers, and asthma exacerbations in older
children (Lau et al., 2007; Khetsuriani et al., 2008; Miller
et al., 2009a; Wisdom et al., 2009b). Contrastingly, one study
described a shorter duration of asthma symptoms and less
cough than seen in HRV-A infection (Arden et al., 2010a).
HRV-C shares a number of features of its genomic
organization with other members of the genus Enterovirus
(Fig. 1b). This includes an approximately 7100 base genome
containing a single reading frame, the absence of a leader
protein, a P1 region encoding four capsid proteins, a 2A
gene encoding a cis-acting proteinase, followed by a series of
non-structural proteins collinear with those of other
enteroviruses, including 3D (which encodes the RNA-
dependent RNA polymerase). HRV-C contains a type I
internal ribosomal entry site that is structurally similar to
and has short regions of striking sequence conservation with
those of other enteroviruses. Members of the genus
Enterovirus do, however, differ in other aspects of their
genome organization. Most evident is the variability in the
position of the cis-acting replication element. This is located
at a homologous position within the 2C coding sequence in
all four human enterovirus (HEV) species A–D, but is
variable in position in each rhinovirus species [within 2A in
HRV-A (Gerber et al., 2001), VP1 in HRV-B and proposed
to be located at the 59 end of VP2 in species C (Cordey et al.,
2008)]. In marked contrast to the ease with which HRV-A
and -B can be isolated, HRV-C has, to date based on the
Fig. 1. (a) Sequence relationships between
species currently assigned to the genus
Enterovirus, depicted by phylogenetic analysis
of aligned sequences from the P1 (capsid
protein-encoding) region [positions 616–
3125, numbered according to the reference
sequence (GenBank accession no.
EF582385); species identified by different
symbols and shading]. The tree was con-
structed by neighbour-joining analysis of pair-
wise amino acid p distances, with branches
showing ¢70% bootstrap support labelled.
The sequence of porcine enterovirus 8 (genus
Sapelovirus) was used as an outgroup. For
presentation purposes, only the 10 most
divergent sequences were included for spe-
cies containing more than 10 sequences
(HEV-A, -B, -C, HRV-A, -B and bovine enter-
oviruses). Bar, amino acid p distance of 0.05. (b)
Diagram of the rhinovirus genome, identifying
the 59- and 39-UTRs and structural (P1) and
non-structural (P2, P3) gene regions, along with
the designations of their encoded proteins. The
genome is drawn to scale, using the complete
genome sequence 024 (GenBank accession
no. EF582385) for numbering.
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published literature, been unculturable in vitro (Lau et al.,
2007; McErlean et al., 2007). Historically, this hindered its
discovery and has additionally precluded investigation of its
antigenic variability, a feature characteristic of other HRVs
and HEVs.
Proposal aims
Genetic characterization of HRV-C amplified from clinical
specimens has provided evidence for extensive heterogeneity
in the VP4/VP2 region, the existence of two phylogenetically
separate groups of sequences in the 59-UTR (one resembling
sequences found in species A rhinoviruses; Han et al., 2009;
Huang et al., 2009; Savolainen-Kopra et al., 2009b; Wisdom
et al., 2009a) and substantial sequence divergence throughout
the genome of the 11 full-length HRV-C sequences obtained
to date (Lamson et al., 2006; Lau et al., 2007; Kistler et al.,
2007; McErlean et al., 2007; Huang et al., 2009; Tapparel et al.,
2009b; Arden et al., 2010b). Although we currently lack the
means to classify HRV-C serologically (as has been achieved
for other rhinovirus and enterovirus species), we recognize
and are responding to the need to develop a classification
system for this species. This will assist in organizing the
rapidly accumulating sequence data currently being generated
from virological and clinical studies, and allow assignment of
uniform type descriptions that will enable comparison of
genetic variants characterized in separate studies over time
and across different geographical regions.
This process is potentially made easier by the evident
similarities in the pattern of sequence divergence of HRV-
C to other rhinoviruses and enteroviruses for which
classification methods have been developed and standar-
dized. For example, the large number of distinct genetic
lineages identifiable by sequence comparisons in the VP4/
VP2 region matches the diversity in this region shown by
different serotypes of species A and B rhinoviruses (Lau
et al., 2009). These differences are mirrored in VP1 (Huang
et al., 2009; Wisdom et al., 2009b; McIntyre et al., 2010)
and other exposed regions of the capsid that underlie the
latter’s putative antigenic diversity. In developing clas-
sification proposals for HRV-C, we have strived to develop
criteria for type assignment that are consistent with the
principles used for other rhinoviruses and enteroviruses,
whilst acknowledging differences in its diversity, genetic
history and biology.
Classification of enteroviruses and rhinoviruses
into serotypes
HRV-A and -B comprise a number of antigenically distinct
viruses designated on the basis of their cross-neutralization
properties in vitro, currently totalling 74 serotypes of HRV-
A and 25 of HRV-B (Kapikian et al., 1967). These totals
incorporate minor adjustments to the original classification
when HRV was subsequently characterized genetically
(Kapikian et al., 1971; Hamparian et al., 1987). As
examples, one of the classical HRV prototypes, HRV-87,
was found to belong to the species HEV-D as a variant of
HEV-68 (Blomqvist et al., 2002). A strain referred to as
Hanks was considered to represent a candidate new type
Fig. 2. Distributions of pairwise nucleotide p (uncorrected)
distances (y-axis) between HRV-A and -B variants around the
previously proposed thresholds (Savolainen et al., 2002) dividing
inter- and intra-serotype distances in VP1 (lower panel) and VP4/
VP2 (upper panel). Pairwise comparisons in the equivalent
distance range for HRV-C are shown for comparison. Unfilled
boxes indicate pairwise distances between HRV variants pre-
viously classified as the same serotype; black-filled boxes, pairwise
comparisons between different serotypes; grey boxes, pairwise
comparisons of variants with unknown serological cross-reactivity
(HRV-C). For clarity, multiple examples of pairwise distances
between the same (sero)type pairs have not been shown.
Classification proposals for HRV-C
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but, on sequence analysis, it was found to be genetically
similar to HRV-21 (Ledford et al., 2004; Laine et al., 2005).
In common with HEVs (Oberste et al., 1999), there is a
close correlation between sequence divergence of HRV-A
and -B in the VP1 region (and other structural genes) and
their designated serotypes (Savolainen et al., 2002; Ledford
et al., 2004; Laine et al., 2005). For HEVs, a nucleotide
sequence divergence value of.25% in VP1 (.15% amino
acid sequence difference) may be used as an alternative
means to classify more recently discovered types without
recourse to extensive serological characterization (Oberste
et al., 1999). Application of this principle has led to the
assignment of 40 genotypically defined enterovirus ‘types’
in addition to the 64 traditionally classified serotypes.
Thresholds of 12% similarly differentiate inter- from intra-
serotype divergences in the VP1 gene of species A and B
rhinoviruses, respectively (Savolainen et al., 2002; McIntyre
et al., 2010), providing the means in principle to detect
novel species A types (e.g. Wisdom et al., 2009b) without
assaying for cross-neutralization (Savolainen et al., 2002).
For rhinoviruses it is, however, recognized that some
inconsistencies and overlap of divergence values between
and within serotypes exist (Savolainen et al., 2002). In
species A, pairwise divergence values in VP1 between
serotypes 95 and 8 (1.6%), serotypes 44 and 29 (7.3%),
serotypes 62 and 25 (9.4%) and serotypes 98 and 54
(11.4%) are interspersed with those observed within
serotypes, as is the pairwise distance between the species
B serotypes 70 and 17 (12.3%) (Fig. 2, lower panel).
Overlaps in inter- and intra-serotype distances, often
involving the same serotype pairs, are also evident from
an equivalent analysis of pairwise distances of VP4/VP2
sequences (Fig. 2, upper panel). In two cases (95/8, 44/29),
reanalysis demonstrated that these pairs did indeed show
cross-neutralization (Cooney et al., 1982; Ledford et al.,
2004), whereas one of the more divergent pairs, 62/25, did
not (Cooney et al., 1982). There is clearly scope to
reinvestigate cross-reactivity of the other discrepant pairs.
Overall, however, the actual distributions of pairwise
distances between different serotypes of HEVs and
rhinoviruses overlap minimally with intra-serotype nuc-
leotide distances (as exemplified by HEV-B and HRV-A;
Fig. 3a, b). For enteroviruses, the lowest value between
these two distributions closely matches the type-assign-
ment threshold now used for genotypic assignment of new
Fig. 3. Distribution of pairwise nucleotide p
distances between: (a) available complete
(.90%) VP1 sequences of HEV-B (n5330);
(b) available complete (.90%) VP1 sequences
of HRV-A (n5279); (c) available VP1 sequences
of HRV-C (n586; .90% complete between
positions 2304 and 3125); (d) all available VP4/
VP2 sequences of HRV-C (n5702; .90%
complete between positions 615 and 1043).
Previously designated (HEV) or proposed type
thresholds are indicated by thick lines.
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types. We propose to adopt this method for a genotypic
classification of HRV-C.
Rhinovirus recombination
The process of recombination creates chimaeric virus
genomes in which different genome regions have separate
evolutionary origins; recombinants may change in their
phylogenetic relationships to other sequences between
genome regions. For enteroviruses and rhinoviruses whose
type assignments are dependent on the capsid genes (and
the encoded differences in antigenic properties), regions
that undergo extremely frequent recombination (such as
the 59-UTR, P2 and P3 non-structural gene regions in
HEV) cannot therefore contribute to their (sero)type
classification (Savolainen-Kopra et al., 2009b).
Rhinovirus species A and B show much more consistent
phylogeny relationships across the genome, as exemplified
by the largely concordant phylogenies of the 3Dpol and
VP4/VP2 regions (Savolainen et al., 2004). There are,
however, some inconsistencies evident on analysis of
complete genome sequences of species A and B
(Palmenberg et al., 2009; Tapparel et al., 2009a). For
example, HRV-53 shows greater similarity to HRV-46 in
the non-structural region than anticipated by their
sequence relationship in the capsid-encoding region, whilst
a similar comparison of HRV-78 and HRV-12 showed
non-structural gene sequences to be more divergent. In
these and other instances, most changes in phylogenetic
relationship occurred at the P1/P2 boundary, implying
separate evolutionary origins for the structural and non-
structural gene blocks in some serotypes.
In contrast to species A and B, our recent extensive
comparison of phylogenies of the VP4/VP2, VP1 and
3Dpol regions of species C demonstrated consistent
branching orders and relative branch lengths in all three
coding regions (McIntyre et al., 2010). However, several
phylogeny violations occurred between the 59-UTR and
VP4/VP2 trees, originating from a series of likely interspecies
recombination events with breakpoints towards the 39 end
of the 59-UTR (Han et al., 2009; Huang et al., 2009;
Savolainen-Kopra et al., 2009b; Wisdom et al., 2009a).
Remarkably, most 59-UTR sequences of species C cluster
within the species A 59-UTR clade, with the remainder
being phylogenetically distinct (Han et al., 2009; Huang
et al., 2009; Savolainen-Kopra et al., 2009b; Wisdom et al.,
2009a). Those with species A-like 59-UTR sequences have
been named HRV-Ca, with the remainder assigned as
HRV-Cc (Huang et al., 2009). We have recently found that
the region of 2A encoding the C-terminal domain of the
proteinase also has a recombinant origin, with all available
HRV-C sequences from this region clustering within the
HRV-A clade (McIntyre et al., 2010). The evolutionary
events and the selection pressures underlying these
instances of HRV-A/-C interspecies recombination are
currently unknown.
HRV-C heterogeneity and proposals for type
assignments
Eleven (near-)complete genome sequences, 541 sequences
from the VP4/VP2 region [.90% complete between
Fig. 4. Phylogenetic analysis of all available sequences of HRV-C in
the VP1 region (.90% complete between positions 2304 and
3125). The tree was constructed by neighbour-joining analysis of
pairwise maximum composite likelihood distances implemented in
the program MEGA (Tamura et al., 2007); branches showing¢70%
bootstrap support are indicated. Complete genome sequences are
labelled$. Bar, maximum composite likelihood distance of 0.05.
Classification proposals for HRV-C
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positions 615 and 1043, numbered here and below using
the complete genome HRV-C sequence 024 (GenBank
accession no. EF582385)] from public databases and a
further 160 unpublished sequences contributed by the
authors of the current study, along with 86 complete VP1
(positions 2304–3125) and 89 partial 3Dpol (positions
6384–6854) sequences, collectively attest to the substantial
genetic heterogeneity of HRV-C. The formation of a
number of discrete clades of HRV-C in each genome
region (Savolainen et al., 2002; McIntyre et al., 2010)
(Fig. 4) supports the idea that genetic variants of HRV-C
might be usefully classified into a number of types,
comparable to types/serotypes of other HRV species.
The current lack of data on antigenic properties of HRV-C is
unlikely to be addressed in the near future, due to difficulties
with in vitro culture and the daunting task of creating and
applying the necessary serotyping reagents should a viral
culture system be developed. These factors necessitate a
genotypic classification method. To investigate whether
clear inter- and intra-type thresholds can be defined for
HRV-C, we constructed a frequency histogram of the set of
pairwise distances between all available sequences from the
VP1 region (Fig. 3c) using previously described methods for
constructing sequence alignments and determining
sequence distances (McIntyre et al., 2010). For comparison,
we have additionally analysed an even larger dataset of
available VP4/VP2 sequences (Fig. 3d).
As described previously (McIntyre et al., 2010), the
distribution of HRV-C VP1 sequence distances is indeed
bimodal, with a clearly defined minimum (zero) value
below 14.9% and above 8% (Fig. 2), which may be used as
a threshold for putative assignment of HRV-C types. This
corresponds closely to the 12% threshold that divides
within- and between-serotype distances in species A and B
rhinoviruses (Savolainen et al., 2002; McIntyre et al., 2010).
The distribution of pairwise distances in the VP4/VP2
region resembles that of VP1, with an equivalent minimum
value corresponding to the type threshold of VP1 at 10%.
However, as a likely result of its shorter length and lesser
degree of sequence diversity than VP1, the type threshold
for VP4/VP2 was less clearly defined (Fig. 2). This pattern
was also found in a similar comparison of VP4/VP2 region
distance distributions in HRV-A and -B (McIntyre et al.,
2010) and in human enteroviruses (Oberste et al., 1999;
Mulders et al., 2000).
Type-assignment proposals
In formulating the following criteria for type assignment,
we are aware of the need for simplicity and transparency in
the assignment process and the use of criteria comparable
to those used for genotypic classification in other
enterovirus species. At the same time, these proposals
should respect and adapt to differences in the pattern of
diversity in species C and the occurrence of recombination.
In addition, we acknowledge that current surveillance and
genetic characterization of HRV-C are incomplete and we
state the need for review of and, if necessary, revision of
type-assignment criteria as further genetic data become
available in the future. Finally, the use of genetic
comparisons in restricted regions of the genome (VP1
and VP4/VP2) should not diminish perceptions of the
importance of other genomic regions in shaping the
phenotype of HRV-C. However, these, together with
putative biological/epidemiological differences to be found
in the future, lie specifically in the realm of research
enquiry and we advise against their use as subsidiary or
alternative classification criteria unless or until there is a
future major reappraisal of our understanding of HRV
diversity and genetics.
(a) A proposed HRV-C type should be phylogeneti-
cally distinct and show .13% nucleotide
sequence divergence in VP1 from all other
Table 1. Proposed assigment of complete genome sequences of HRV-C into types
Type
assignment
GenBank
accession no.
Strain identifier Submission Variants Reference*
VP4/VP2 VP1
HRV-C1 EF077279 NAT001 20 Oct 2006 17 4 Kistler et al. (2007)
HRV-C2 EF077280 NAT045 20 Oct 2006 36 1 Kistler et al. (2007)
HRV-C3 EF186077 QPM 14 Dec 2006 12 2 McErlean et al. (2007)
HRV-C4 EF582385 024 27 Apr 2007 3 1 Lau et al. (2007)
HRV-C5 EF582386 025 27 Apr 2007 22 1 Lau et al. (2007)
HRV-C6 EF582387 026 27 Apr 2007 32 11 Lau et al. (2007)
HRV-C7 DQ875932 NY-074 14 Jul 2008 4 2 Lamson et al. (2006)
HRV-C8 GQ223227 N4 29 May 2009 6 2 Huang et al. (2009)
HRV-C9 GQ223228 N10 29 May 2009 27 5 Huang et al. (2009)
HRV-C10 GQ323774 QCE 29 Jun 2009 7 1 Arden et al. (2010b)
HRV-C11 EU840952 CL-170085 21 May 2010 11 2 Tapparel et al. (2009b)
*Reference for first submitted sequence for each type.
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Table 2. Proposed type assigment of HRV-C variants represented by VP1 (and VP4/VP2) sequences
Type assignment VP4/VP2 region VP1 region References*
GenBank
accession no.
Submission date Variants GenBank
accession no.
Submission date Variants
HRV-C12 EF077264 20 Oct 2006 25 HM236958 14 May 2010 3 Kistler et al. (2007); McIntyre et al. (2010)
HRV-C13 EU081795 3 Aug 2007 6 HM236908 14 May 2010 1 Renwick et al. (2007); McIntyre et al. (2010)
HRV-C14 EU081796 3 Aug 2007 6 HM236911 14 May 2010 1 Renwick et al. (2007); McIntyre et al. (2010)
HRV-C15 EU081800 3 Aug 2007 22 HM236963 14 May 2010 1 Renwick et al. (2007); McIntyre et al. (2010)
HRV-C16 EU081808 3 Aug 2007 31 HM236944 14 May 2010 3 Renwick et al. (2007); McIntyre et al. (2010)
HRV-C17 EU081809 3 Aug 2007 3 HM236936 14 May 2010 1 Renwick et al. (2007); McIntyre et al. (2010)
HRV-C18 EU590074 25 Mar 2008 30 HM236918 14 May 2010 5 Savolainen-Kopra et al. (2009a); McIntyre et al. (2010)
HRV-C19 EU697850 5 May 2008 9 EU840728 20 Jun 2008 3 Briese et al. (2008); Tapparel et al. (2009a)
HRV-C20 EU697851 5 May 2008 14 HM236923 14 May 2010 6 Briese et al. (2008); McIntyre et al. (2010)
HRV-C21 EU752377 26 May 2008 16 HM236903 14 May 2010 2 Miller et al. (2009a); McIntyre et al. (2010)
HRV-C22 EU752381 26 May 2008 10 HM236905 14 May 2010 2 Miller et al. (2009a); McIntyre et al. (2010)
HRV-C23 EU752424 26 May 2008 21 HM236901 14 May 2010 2 Miller et al. (2009a); McIntyre et al. (2010)
HRV-C24 EU752426 26 May 2008 14 HM236939 14 May 2010 1 Miller et al. (2009a); McIntyre et al. (2010)
HRV-C25 EU752427 26 May 2008 15 HM236952 14 May 2010 1 Miller et al. (2009a); McIntyre et al. (2010)
HRV-C26 EU752441 26 May 2008 19 HM236904 14 May 2010 2 Miller et al. (2009a); McIntyre et al. (2010)
HRV-C27 GQ223122 9 Jan 2009 14 HM236906 14 May 2010 4 Huang et al. (2009); McIntyre et al. (2010)
HRV-C28 GQ223134 9 Jan 2009 11 HM236954 14 May 2010 1 Huang et al. (2009); McIntyre et al. (2010)
HRV-C29 FJ615699 9 Jan 2009 4 HM236949 14 May 2010 1 Miller et al. (2009b); McIntyre et al. (2010)
HRV-C30 GQ476669 13 Aug 2009 2 HM236968 14 May 2010 1 Wisdom et al. (2009b); McIntyre et al. (2010)
HRV-C31 GU294380 4 Dec 2009 4 HM236964 14 May 2010 1 Wisdom et al. (2009b); McIntyre et al. (2010)
HRV-C32 GU294466 4 Dec 2009 13 HM236897 14 May 2010 10 Wisdom et al. (2009b); McIntyre et al. (2010)
HRV-C33 GU294480 4 Dec 2009 3 HM236934 14 May 2010 2 Wisdom et al. (2009b); McIntyre et al. (2010)
*References for first submitted sequence for each type.
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previously classified species C types. The VP1
sequence obtained for this sequence comparison
must be .90% complete between positions 2304
and 3125 for determining valid nucleotide
sequence distances. The proposed threshold
corresponds to approximately 8% amino acid
sequence divergence in VP1. However, for clarity
and avoidance of conflicting assignments, we do
not propose amino acid distances as an additional
or alternative criterion for type assignments.
(b) A sequence from the VP4/VP2 region (between
positions 615 and 1043) can be used for
identification of HRV-C types among the much
larger dataset of VP4/VP2 sequences that have
been obtained from surveillance studies.
(c) Types should be numbered sequentially from 1
using a ‘C’ prefix to distinguish them from
serotype designations of other HRV species. In
the tables of assignments drawn up, numbering
commences with the 11 (near)-complete genome
sequences HRV-C1 to -C11 (Table 1), based on
submission date to GenBank.
(d) Subsequent assignments have been made (HRV-
C12 onwards) to genetic variants of HRV-C for
which VP1 and VP4/VP2 sequences are available,
again ordered by submission date of the first
sequence in either VP4/VP2 or VP1 (Table 2).
(e) The remaining genetic variants of HRV-C for
which only VP4/VP2 region sequences are
available and which show .10% divergence from
other species C sequences in this region should be
assigned as provisionally assigned types (desig-
nated ‘pat’), e.g. HRV-C_pat1, HRV-C_pat2 etc.
(Table 3). If and when VP1 sequence data are
determined for at least one member of this
provisionally assigned type, it can be added to
the list of confirmed types and removed from the
provisional list.
(f) A designated Expert Group takes responsibility
for the future coordinated assignment of HRV-C
types, including a reappraisal of the type assign-
ment as more sequence data accumulate. This
might perhaps be nominated by the ICTV
Picornavirus Study Group and include Study
Table 3. Provisional type assignment of HRV-C variants represented by VP4/VP2 sequences only
Provisional type GenBank accession no. Submission date Variants Reference*
HRV-C_pat1 EF077256 20 Oct 2006 21 Kistler et al. (2007)
HRV-C_pat2 EF077260 20 Oct 2006 8 Kistler et al. (2007)
HRV-C_pat3 EU081790 3 Aug 2007 15 Renwick et al. (2007)
HRV-C_pat4 EU081791 3 Aug 2007 13 Renwick et al. (2007)
HRV-C_pat5 EU081799 3 Aug 2007 20 Renwick et al. (2007)
HRV-C_pat6 EU081802 3 Aug 2007 29 Renwick et al. (2007)
HRV-C_pat7 EU081803 3 Aug 2007 7 Renwick et al. (2007)
HRV-C_pat8 EU081805 3 Aug 2007 11 Renwick et al. (2007)
HRV-C_pat9 EU081807 3 Aug 2007 13 Renwick et al. (2007)
HRV-C_pat10 EU590054 25 Mar 2008 14 Savolainen-Kopra et al. (2009a)
HRV-C_pat11 EU590061 25 Mar 2008 5 Savolainen-Kopra et al. (2009a)
HRV-C_pat12 EU590064 25 Mar 2008 5 Savolainen-Kopra et al. (2009a)
HRV-C_pat13 EU697839 5 May 2008 6 Briese et al. (2008)
HRV-C_pat14 EU697852 5 May 2008 1 Briese et al. (2008)
HRV-C_pat15 EU743925 22 May 2008 10 Dominguez et al. (2008)
HRV-C_pat16 EU752358 26 May 2008 2 Miller et al. (2009a)
HRV-C_pat17 EU752398 26 May 2008 6 Miller et al. (2009a)
HRV-C_pat18 EU752412 26 May 2008 21 Miller et al. (2009a)
HRV-C_pat19 FJ598096 29 Dec 2008 5 Currently unpublished
HRV-C_pat20 FJ615722 9 Jan 2009 1 Miller et al. (2009b)
HRV-C_pat21 FJ615737 9 Jan 2009 4 Miller et al. (2009b)
HRV-C_pat22 FJ615745 9 Jan 2009 1 Miller et al. (2009b)
HRV-C_pat23 FJ841957 17 Mar 2009 2 Calvo et al. (2009)
HRV-C_pat24 FJ869923 27 Mar 2009 1 Calvo et al. (2009)
HRV-C_pat25 FJ869950 27 Mar 2009 4 Calvo et al. (2009)
HRV-C_pat26 GQ466482 7 Aug 2009 1 Savolainen-Kopra et al. (2009c)
HRV-C_pat27 GU214340 18 Nov 2009 5 Piralla et al. (2009)
HRV-C_pat28 HM347248 24 May 2010 1 Currently unpublished
*Reference for first submitted sequence for each type.
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Group members with expertise and experience in
new enterovirus type assignments, as well as
‘outside’ scientists active in HRV-C or more
general HRV research.
(g) Alignments of the VP1 and VP4/VP2 regions,
along with information on the regions used for
sequence comparisons, will be made available on
a publicly available database accessible through
the Picornavirus Study Group. These alignments
will be regularly maintained and updated with
new sequence data and type assignments as these
become available.
(h) This Group should cooperate closely with those
developing future type-assignment criteria for
species A and B rhinoviruses to help ensure
consistency in approach.
Applying these criteria to the currently available dataset of
HRV-C sequences creates a total of 33 confirmed types
(Tables 1 and 2) and a further 28 provisionally assigned
types based on VP4/VP2 sequences (Table 3).
Type identification
In drawing up specific classification proposals, we should
emphasize that the process of type assignment is an activity
distinct from type identification or detection. From the data
obtained from genetic characterization of HRV-C in different
genome regions and the lack of recombination observed
(McIntyre et al., 2010), we consider that identification of an
HRV-C genetic variant as belonging to an already classified
type can be achieved by sequence comparisons in VP4/VP2.
Currently, most sequence data obtained for genetic char-
acterization of HRV-C have been obtained in this region,
including all of the confirmed types. These sequence data are
derived from a wide geographical base, combining sequence
data from Europe, USA, Australia, Japan and South-East Asia.
By phylogenetic analysis and examination of pairwise
distances within the now-extensive dataset of VP4/VP2
sequences, the aforementioned threshold permits all HRV-C
variants characterized to date to be categorized into a total of
61 confirmed or provisionally assigned types, the majority of
which now contain multiple examples from geographically
separate locations (Fig. 5; a full list of individual assignments
is available as Supplementary Table S1 in JGV Online). The
decreasing pace of identification of variants worldwide that
can be assigned (even provisionally) as new types suggests a
finite limit to the number that will eventually be classified.
The actual total will, however, only become clear with more
temporally and geographically widespread sampling.
In summary, this proposal draws together existing know-
ledge of the genetic diversity of HRV-C and applies
principles established for type assignment of other entero-
viruses to create a genotypically based classification scheme
for HRV-C types. We hope that these proposals will be of
value in future rhinovirus research, and provide the impetus
to develop related type-assignment criteria for novel HRV-A
and -B genetic variants that have been described.
Fig. 5. Total numbers of each assigned HRV-C type identified by sequence comparisons in the VP4/VP2 region, divided by
geographical region. The total representation of sequences from each geographical range is indicated by the inset pie chart.
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